These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
495 related items for PubMed ID: 25912464
1. Early brain magnetic resonance imaging can predict short and long-term outcomes after organophosphate poisoning in a rat model. Shrot S, Tauber M, Shiyovich A, Milk N, Rosman Y, Eisenkraft A, Kadar T, Kassirer M, Cohen Y. Neurotoxicology; 2015 May; 48():206-16. PubMed ID: 25912464 [Abstract] [Full Text] [Related]
2. Using MRI for the assessment of paraoxon-induced brain damage and efficacy of antidotal treatment. Rosman Y, Eisenkraft A, Krivoy A, Schein O, Makarovski I, Shrot S, Ramaty E, Shilderman EB, Kapon J, Gilat E, Kadar T, Maier S, Daniels D, Shneor R, Salomon S, Tamar G, Last D, Mardor Y. J Appl Toxicol; 2012 Jun; 32(6):409-16. PubMed ID: 21861267 [Abstract] [Full Text] [Related]
3. Early in vivo MR spectroscopy findings in organophosphate-induced brain damage-potential biomarkers for short-term survival. Shrot S, Anaby D, Krivoy A, Makarovsky I, Rosman Y, Bloch-Shilderman E, Lazar S, Bar-Shir A, Cohen Y. Magn Reson Med; 2012 Nov; 68(5):1390-8. PubMed ID: 22247007 [Abstract] [Full Text] [Related]
4. Prevention of organophosphate-induced chronic epilepsy by early benzodiazepine treatment. Shrot S, Ramaty E, Biala Y, Bar-Klein G, Daninos M, Kamintsky L, Makarovsky I, Statlender L, Rosman Y, Krivoy A, Lavon O, Kassirer M, Friedman A, Yaari Y. Toxicology; 2014 Sep 02; 323():19-25. PubMed ID: 24881594 [Abstract] [Full Text] [Related]
5. Addition of ketamine to standard-of-care countermeasures for acute organophosphate poisoning improves neurobiological outcomes. Lewine JD, Weber W, Gigliotti A, McDonald JD, Doyle-Eisele M, Bangera N, Paulson K, Magcalas C, Hamilton DA, Garcia E, Raulli R, Laney J. Neurotoxicology; 2018 Dec 02; 69():37-46. PubMed ID: 30172622 [Abstract] [Full Text] [Related]
6. Neuroprotective efficacy of decompressive craniectomy after controlled cortical impact injury in rats: An MRI study. Tian R, Han L, Hou Z, Hao S, Mao X, Zhu Z, Tao X, Zhang Q, Liu B. Brain Res; 2015 Oct 05; 1622():339-49. PubMed ID: 26168891 [Abstract] [Full Text] [Related]
7. Brief isoflurane administration as a post-exposure treatment for organophosphate poisoning. Krishnan JKS, Figueiredo TH, Moffett JR, Arun P, Appu AP, Puthillathu N, Braga MF, Flagg T, Namboodiri AM. Neurotoxicology; 2017 Dec 05; 63():84-89. PubMed ID: 28939237 [Abstract] [Full Text] [Related]
8. Intranasal delivery of obidoxime to the brain prevents mortality and CNS damage from organophosphate poisoning. Krishnan JKS, Arun P, Appu AP, Vijayakumar N, Figueiredo TH, Braga MFM, Baskota S, Olsen CH, Farkas N, Dagata J, Frey WH, Moffett JR, Namboodiri AMA. Neurotoxicology; 2016 Mar 05; 53():64-73. PubMed ID: 26751814 [Abstract] [Full Text] [Related]
9. Temporal and regional changes after focal traumatic brain injury. Lescot T, Fulla-Oller L, Po C, Chen XR, Puybasset L, Gillet B, Plotkine M, Meric P, Marchand-Leroux C. J Neurotrauma; 2010 Jan 05; 27(1):85-94. PubMed ID: 19705964 [Abstract] [Full Text] [Related]
10. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats. Kassa J, Kunesova G. J Appl Toxicol; 2006 Jan 05; 26(4):309-16. PubMed ID: 16552727 [Abstract] [Full Text] [Related]
11. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study. Braun KP, van Eijsden P, Vandertop WP, de Graaf RA, Gooskens RH, Tulleken KA, Nicolay K. J Neurosurg; 1999 Oct 05; 91(4):660-8. PubMed ID: 10507389 [Abstract] [Full Text] [Related]
12. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study. Bladowska J, Zimny A, Knysz B, Małyszczak K, Kołtowska A, Szewczyk P, Gąsiorowski J, Furdal M, Sąsiadek MJ. J Hepatol; 2013 Oct 05; 59(4):651-7. PubMed ID: 23680314 [Abstract] [Full Text] [Related]
15. [Brain metabolic disorders after chemotherapy in the study by magnetic resonance spectroscopy]. Ciszkowska-Łysoń B, Królicki L, Teska A, Janowicz-Zebrowska A, Krzakowski M, Tacikowska M. Neurol Neurochir Pol; 2003 Oct 05; 37(4):783-98. PubMed ID: 14746239 [Abstract] [Full Text] [Related]
16. Assessment of mitochondrial impairment in traumatic brain injury using high-resolution proton magnetic resonance spectroscopy. Signoretti S, Marmarou A, Aygok GA, Fatouros PP, Portella G, Bullock RM. J Neurosurg; 2008 Jan 05; 108(1):42-52. PubMed ID: 18173309 [Abstract] [Full Text] [Related]
17. Immunomodulation by poly-YE reduces organophosphate-induced brain damage. Finkelstein A, Kunis G, Berkutzki T, Ronen A, Krivoy A, Yoles E, Last D, Mardor Y, Van Shura K, McFarland E, Capacio BA, Eisner C, Gonzales M, Gregorowicz D, Eisenkraft A, McDonough JH, Schwartz M. Brain Behav Immun; 2012 Jan 05; 26(1):159-69. PubMed ID: 21925261 [Abstract] [Full Text] [Related]
18. The evaluation of neuroprotective efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats. Kassa J, Karasova J, Vasina L. J Appl Toxicol; 2007 Jan 05; 27(6):621-30. PubMed ID: 17685413 [Abstract] [Full Text] [Related]
20. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III. Vagnozzi R, Signoretti S, Tavazzi B, Floris R, Ludovici A, Marziali S, Tarascio G, Amorini AM, Di Pietro V, Delfini R, Lazzarino G. Neurosurgery; 2008 Jun 05; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995 [Abstract] [Full Text] [Related] Page: [Next] [New Search]